www.omniab.com
Open in
urlscan Pro
2a06:98c1:3121::3
Public Scan
Submitted URL: http://www.omniab.com/
Effective URL: https://www.omniab.com/
Submission: On November 15 via api from ES — Scanned from NL
Effective URL: https://www.omniab.com/
Submission: On November 15 via api from ES — Scanned from NL
Form analysis
0 forms found in the DOMText Content
Skip to content * About Menu Toggle * Overview * Team * Board of Directors * Careers * Technology Menu Toggle * Overview * Antigen Design * Antibody Generation Menu Toggle * OmniRat * OmniMouse * OmniChicken * OmnidAb * OmniTaur * Bispecific Platforms * Screening Menu Toggle * GEM * xPloration * Antibody Optimization Menu Toggle * Fc-Silencing Technology * Ion Channel and Transporter Technology * In Silico Technologies * Scientific Publications * Partnerships Menu Toggle * Overview * Why Partner with OmniAb? * Partner Pipeline * Contact Business Development * Investors Menu Toggle * Overview * News * Events & Presentations * Stock Info * SEC Filings * Governance Menu Toggle * Governance Documents * Executive Officers * Board of Directors * Board Committees * Resources Menu Toggle * Investor FAQs * Information Request Form * Investor Email Alerts * Investor Contacts * Contact Main Menu * About Menu Toggle * Overview * Team * Board of Directors * Careers * Technology Menu Toggle * Overview * Antigen Design * Antibody Generation Menu Toggle * OmniRat * OmniMouse * OmniChicken * OmnidAb * OmniTaur * Bispecific Platforms * Screening Menu Toggle * GEM * xPloration * Antibody Optimization Menu Toggle * Fc-Silencing Technology * Ion Channel and Transporter Technology * In Silico Technologies * Scientific Publications * Partnerships Menu Toggle * Overview * Why Partner with OmniAb? * Partner Pipeline * Contact Business Development * Investors Menu Toggle * Overview * News * Events & Presentations * Stock Info * SEC Filings * Governance Menu Toggle * Governance Documents * Executive Officers * Board of Directors * Board Committees * Resources Menu Toggle * Investor FAQs * Information Request Form * Investor Email Alerts * Investor Contacts * Contact PUSHING THE FOREFRONT OF THERAPEUTIC ANTIBODY DISCOVERY OmniAb® provides our pharmaceutical industry partners access to the most diverse antibody repertoires and cutting-edge screening technologies to enable discovery of next-generation therapeutics. DISCOVER THE ADVANTAGE OF CHOOSING OMNIAB FOR ANTIBODY DISCOVERY OmniAb partners enjoy full access to the most comprehensive and cutting-edge suite of clinically proven antibody discovery technologies available. LEARN ABOUT HOW OMNIAB WILL BEST HELP YOUR PROGRAM. DISCOVER OUR TRANSGENIC ANIMAL PLATFORMS. INTRODUCTION TO A UNIQUE INNOVATION IN TRANSGENIC ANIMAL PLATFORMS Because chickens are evolutionarily more distant than rodents are to humans, they produce stronger and more diverse antibody responses to many target antigens, especially those that are conserved among mammals. This makes chickens ideal immunization hosts for therapeutic antibody discovery. Learn About OmniChicken WHAT'S NEW AT OMNIAB Read the latest news and press releases about OmniAb technology. Read News & Press Releases LIGAND ANNOUNCES THAT JANSSEN HAS RECEIVED APPROVAL FROM EUROPEAN COMMISSION... LIGAND TO SPIN-OFF ITS OMNIAB BUSINESS THROUGH MERGER WITH AVISTA... PUBLICATIONS & PRESENTATIONS Search and browse recent presentations and peer-reviewed publications about OmniAb technology View Publications COMMON LIGHT CHAIN CHICKENS PRODUCE HUMAN ANTIBODIES OF HIGH AFFINITY AND BROAD EPITOPE COVERAGE FOR THE ENGINEERING OF BISPECIFICS. OMNICLIC: TRANSGENIC CHICKENS PRODUCING HUMAN ANTIBODIES FOR BISPECIFICS. BECOME AN OMNIAB PARTNER See how more than 75 biopharmaceutical companies and research institutions worldwide are using OmniAb technology and capabilities to advance clinical drug development. Partner With Us GET IN TOUCH Learn about our antibody discovery services and find out which could work best for you. Contact Us About * Overview * Team * Board of Directors * Careers PARTNERSHIPS * Overview * Why Partner with OmniAb? * Partner Pipeline * Contact Business Development TECHNOLOGY * Overview * Antigen Design * Antibody Generation * Screening * Antibody Optimization * Ion Channel and Transporter Technology * Scientific Publications OmniAb, Inc. 5980 Horton Street Suite 600 Emeryville, CA 94608 Contact | Privacy Policy | Disclaimer © 2023 OmniAb, Inc. All rights reserved. previousnextslideshow